Description
Referenced Citations
- Kolomin, T., et al. (2013). A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neuroscience and Behavioral Physiology, 43(7), 880-891. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/23864238/ - Zozulya, A.A., et al. (2008). Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova, 108(4), 38-48. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/18427477/ - Volkova, A., et al. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 7, 31. [Online].
Available: https://www.frontiersin.org/articles/10.3389/fphar.2016.00031/full - Medvedev, V.E., et al. (2015). Optimization of anxiolytic therapy with selank in patients with anxiety-asthenic disorders. Zh Nevrol Psikhiatr Im S S Korsakova, 115(6), 33-40. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/26356705/ - Peptide Sciences. (2024). N-Acetyl Selank Amidate 10mg. [Online].
Available: https://www.peptidesciences.com/n-acetyl-selank-amidate-10mg